JNCI Monographs · 2019 · 28 citations · 13 references
MedicineOncologyCancer EpidemiologyClinical EpidemiologyEpidemiologic MethodsCancer Burden AssessmentColorectal CancerCost Data CollectionDirect Medical CostsHealth Care CostsHealthcare Cost AnalysisCancer Cost BurdenColorectal Cancer EpidemiologyEconomic Burden Of CancerHealth Care Cost IdentificationHealthcare Cost ConsiderationMatched StudiesMedicare Data MatchingPatient Cost Estimation
Medical care costing studies have excluded patients with a prior cancer history. This study aims to update methods for estimating medical care costs attributable to cancer and to evaluate the effect of a prior history of cancer on costs for colorectal cancer (CRC) patients. We used Surveillance, Epidemiology, and End Results (SEER)-Medicare data and matched cancer patients to controls without cancer to estimate cancer-attributable costs by phases of care using Medicare 2007-2013 claims. CRC annualized average cancer-attributable costs were $56.0 K, $5.3 K, $92.5 K, and $24.3 K in the initial, continuing, and end-of-life cancer and noncancer death phases, respectively, in 2014 dollars. Costs were higher for patients diagnosed with more advanced stage, younger ages, and nonwhite races. Costs for patients with prior cancers were consistently higher than patients without prior cancers, especially in the continuing (4.9 K vs 7.2 K) and end-of-life noncancer death (22.7 K vs 30.0 K). Our CRC costs improve previous estimates by using more recent data and updated methods.
13
Obtaining Long-Term Disease Specific Costs of Care
Martin L. Brown, Gerald F. Riley, Arnold L. Potosky et al. · Medical Care · 1999 · 180 citations